NCT04035681

Brief Summary

The purpose of this feasibility study is to determine whether it is practical and helpful to provide problem-solving therapy to stroke survivors and their spouses/partners (caregivers) together. It will also compare the experiences of participants who receive problem-solving therapy to those who receive stroke-related health education. Many stroke survivors and caregivers report feeling sad or blue at some point after the stroke. These feelings can impact quality of life. Encountering problems is a part of daily life. These problems can be big or small, but sometimes they can pile up and feel overwhelming, contributing to feelings of sadness. Problem-solving therapy is a tool that teaches structured ways to address current problems or challenges in your life. Participants who are assigned to receive problem-solving therapy will work with a research team member for six, one-hour sessions. During each session, participants will identify a problem (big or small) and create a plan to work on that problem. Participants who are assigned to receive stroke-related health education will work with a research team member who will teach them about various topics related to stroke over six, one-hour sessions. Each session will cover information about a different topic related to stroke. Outcomes data will be collected at approximately 4 weeks, 8 weeks, and 13 weeks from baseline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 10, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 24, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 29, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2020

Completed
Last Updated

September 2, 2020

Status Verified

March 1, 2020

Enrollment Period

12 months

First QC Date

July 24, 2019

Last Update Submit

September 1, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Study Retention

    Total percentage of participants who complete the study.

    Through study completion, an average of 13 weeks.

  • Protocol Adherence

    Total percentage of protocol-specified activities completed by enrolled participants.

    Through study completion, an average of 13 weeks.

  • Intervention Acceptability

    Participant experience collected via self-report survey.

    Post-intervention, at approximately 8 weeks.

  • Study Recruitment Success

    Percentage of eligible candidates who enroll in the study.

    At initial contact.

Secondary Outcomes (4)

  • Pre/post-intervention changes in depressive symptoms among caregivers.

    Baseline and post-intervention, covering an average of 8 weeks.

  • Pre/post-intervention changes in quality of life among caregivers.

    Baseline and post-intervention, covering an average of 8 weeks.

  • Pre/post-intervention changes in depressive symptoms among stoke survivors.

    Baseline and post-intervention, covering an average of 8 weeks.

  • Pre/post-intervention changes in quality of life among stoke survivors.

    Baseline and post-intervention, covering an average of 8 weeks.

Study Arms (2)

Problem-Solving Therapy

EXPERIMENTAL

Participants who are assigned to receive problem-solving therapy will work with a research team member for six, one-hour sessions. During each session, participants will identify a problem (big or small) and create a plan to work on that problem.

Behavioral: Problem-Solving Therapy

Stroke-Related Health Education

ACTIVE COMPARATOR

Participants who are assigned to receive stroke-related health education will work with a research team member who will teach them about various topics related to stroke over six, one-hour sessions. Each session will cover information about a different topic related to stroke.

Other: Stroke-Related Health Education

Interventions

Problem-Solving Therapy is a brief psychosocial intervention for management of depressive symptoms. Participants will have six, one-hour sessions with an interventionist to learn a structured approach to problem-solving.

Problem-Solving Therapy

The stroke-related health education program will teach participants about various topics related to stroke. Participants will have six, one-hour sessions with an interventionist to learn about different topics related to stroke.

Stroke-Related Health Education

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Both dyad participants are at least 18 years of age.
  • The stroke survivor experienced an ischemic or hemorrhagic stroke at least 3 months prior to enrollment.
  • The caregiver is a spouse/partner who provides regular, unpaid support for the survivor in activities of daily living.
  • Both dyad members are willing and able understand and comply with protocol requirements.

You may not qualify if:

  • The stroke survivor has severe expressive or receptive aphasia or global aphasia, as documented in the medical record by a speech pathologist or other provider.
  • Either dyad member is unable to write, as this will interfere with completion of MiniCog assessment.
  • Either dyad member has significant cognitive impairment, evidenced by MiniCog score \<4 at screening.
  • Either dyad member reports an intent to harm him/herself or others.
  • Either dyad member has any concurrent conditions that would interfere with participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Allina Health

Minneapolis, Minnesota, 55407, United States

Location

MeSH Terms

Conditions

StrokeDepression

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2019

First Posted

July 29, 2019

Study Start

June 10, 2019

Primary Completion

June 2, 2020

Study Completion

July 22, 2020

Last Updated

September 2, 2020

Record last verified: 2020-03

Locations